Transpulmonary passage of echo contrast (Albunex) predicts hemodynamics in chronic heart failure  by Sherman, H.L. et al.
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~ T ran lpu lmonary  of  Echo Contrast  P ln l l t  
(Albunex) Predlots Homodynsml©a in Chronic 
Heart Failure 
H,L, Sherman, H, Oral, A, Marie Oaly, J,M, Nlcklas, W,F, Armstrong, 
Unlv~r#t~/ of Michigan, Ann Arbor, MI, U~ 
The phymt0sl examination In patient8 (pit) with chronlo congestive heart 
failure (CHF) le often nondlagnoatlo, Aggressive mansg~ment of theme pie 
to reNuce pulmonary artery systolic preslure (PASP) and pulmonary capll. 
lary wedge pressure (POWP) neoaultotem pertain Inveslve monitoring with 
right heart catheterization (RHC), Thldy ptl with ohronlo 13HF due to ear, 
dlomyopathy underwent graded pobulamlne (dob) infusion (baseline, 8, t0, 
20; ug/kg/min 8 sin allzges) with 8 mt Atbunex (Albx) InJooted IV at eaah 
atoll, The lout.chamber vtgw was imaged oontlnuously to determine the 
dose It whk:h AIbx apptem¢l in the left ventdota (LV), All pie had RHC to 
dottrmi~ PABP and POWP immediately prior to study. PASP and POWP 
d(ffered slgnlfloantiy between pt groups in whloh trenspulmonery passage ot 
AIt)x o~urrad el different dora  of dob (p ,. O,00~, p ,~ 0,001 respe©tlvely), 
dose of dob at which Albx appeerad In the LV correlated with baseline 
PCWP, PA~P, end CI (r ~ o,ee, p .  o,00~; r • o,so, p .  0,o=3; r - 1.o s?4, p 
.0,0~ respectively), 'rmnspulmonae/passage of Atbx at e dose el dob ~5 
ug/kg/mln predlotod PCWP ~=O mmHg with a PPV .~ 100%, NPV = 8~%, 
Failure of AIb~ to ~ppe~r In the LV at ~ dob dose of tO ug/kghllln had e PPV 
100%, NPV, 00% to do1~ot ~ POWP ~=O mmHg and a PPV ~, I00%, NPV =~ 
(17% to dott~t e PAg~P 40 mmHg, Failure o! Albx to appear el ®b dose :~0 
ug/kg/mln ~dentlfled 8/'/pt~ with PASP ~,00 mmHg and PCWP :~30 mmHg, 
Incremental dot) Infusion with Albs Injootl0ns oan be used to q~l~kly estimate 
PA~P af~ PCWP in pt~ with chronic CHF end reliably identifies pstlant~ with 
hot~ etovated ana no~al p~sures, 
A Nonlnvealve Method for Predlotlng Pulmonary 
z;aplllary Wedge Premium In patients With Heart 
Failure 
O,L, Morass, O,R, Dobroskt, E,H. Awlry, KM, Mclnlyre, M,T, Staw~ky, 
M,M, Givens, W,S, Coluccl, 8o~n Medtca~ Conic, r, 8o~lon, MS, USA 
lo p~ttcNt with h~rt failure (HF), the estimation ot puheeaary capillary 
w~ pressure (PCWP) by physical examination Is notoriously Inaccurate, 
The VERICOR "= (VER) is e semi-automated, noninvaaive device which uses 
the fall In artefiat pressure measure~ In a finger dufitlg ~ Vat~,~lva maneuver 
to, pree~t he PCWP, This device has not been evatu~tnd in patients with 
HI=, To determine whether the VER can be applied to patients with HF, we 
prospeottvety measured the PCWP Invaslvely by fight head catheterization 
and ~onlnvsslvety by VER in 22 patients with NYHA class Ill-IV HF (age, 65 
12 ym,: LVEF, 26 t: 7%; C,I, = 21 ~. 0.4 l/sin/m2 expressed as mean 
4, SEM), Two patients were excluded becauea of technically inadequate 
tracings, The Invaslve PCWP (I PCWP) averaged 21 ~: 8 mmHg (range, 
?-35 mmHg), The PCwP determined simultaneously in a blinded manner 
by VER (N| PCWP) correlated strongly with I PCWP (R = 0,86 by linear 
regression; p < 0,00001; figure). In addition, the VER correctly predicted 
whether the PCWP was above or below 20 mmHg in 9Q% of patients, 
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Conclusion: The VER nonlnvsslvely pred!cts PCWP in patients with meal- 
crete to severn HE It may thus be used as a simple screening m~lhed for 
detecting an elevated PCWP and as a useful guide to therapies aimed at 
lowering the PCWP. 
~ T h e  COST Study: A Multlcenter Trial Compar ing 
Measurements of  Cardiac Output by Thoracic 
Elet:trlcet Blolmpedanoe With Thermodl lut lon 
A. Raisinghanl, N.V. Disco, S.W, Sageman, B,D, Spless, B,R, Williams, 
P. Belott, K. Ohmod, A.N. DeMarla, University of Catifornia arson Diego. 
San Diego. CA, USA 
Measurement of cardiac output (CO) is of fundamental importance in as- 
sessing cardiac performance and determining therapy in pts with heart dis- 
eeca, However, conventional tharmedllution (TO) approaches require cardiac 
cathalarlzation, Recent developments have resulted In refinKI Instmmen. 
lotion capable of providing measures of CO from recordings of thoracic 
electrical blolmpadonca (TEe). The COST Study la e multi-center (6) ef- 
fort to determine the correlation between TO end TEB measures of CO, To 
this point 96 pie have been anrelled. 48% males, 52% fematas, ranging in 
ago from S2-.BS, mean 78 yearn, All pie underwent Swon'(~lenz fight heaP. 
catheterization for clinical indlaatlons, Including: CHF, SllOrk, MI end eleotive 
catheterization, Phi were excluded for septic shack, severe valvular egu~. 
lotion, HR ~t80, mean PB ~.I00, weight ~lSS kg, en~ I~ht  ~.~J0 ca, CO 
by TO wee taken as tilt average of 2-S Injq~'tiona, TEe well obtained from 
conducllvlly within the thorax dating low veltep cunthlt delivery to the ¢~est 
w~ll recorded by shin elo¢ieodos, CO ranged from 2,42-Q,~ Itmln (huron 
8D B,23 ~ 1,7) by TD and 1,58.-10,0 Pain (4,0 ~ t,e) by ~B (p ,~ 001)~ 
Linear regression anatymla reveoted A correlation of r ~ 0,70 t~tw~n TO end 
TEB, 
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ThUS, relined inMmmonistion provide8 meaaurea of CO by TEe which 
gormlate well with thce¢ by TO, This method should be of value in the.. 
noninvasive assassment el cerdlao output and treatment of pie with heart 
disease, 
• I~ l lnKt lon  o f  Relat ive 8yMol ie  and Oleatolle 
Componard8 of  Congut lve  Heart Failure In 
Patients 
C,H, Lorenz, S,J, KovAcs, 0, Gopatakfishnan, K,J, Lunn, S.A, Wmklme 
Barnes.JewLeh Hob?at, Washington University School of t ~ ,  St 
Lou~ MO, USA 
To define the reletive contribution of systolic and diastolic dysfunction !o 
clinical congestive head failure, we studied 14 CHF patients (4 F, t 0 M, NYHA 
Class 1.8 ~ 0.6) and two healthy conhol subjects with cine MRI to compute 
LV volume throughout he cardiac cycle, and LVEDV, LVESV, El:, and peak 
eady filling rate (end-disstellc volume/s), m addition, they magnitude of early 
diastolic tiUmg volume was measured as e percentage of LVEDV (or the 
"diastesis volume-%'), The patients were classified based on their systolic 
function; <35%, 36-55%, and -5,5%. Peak filling rate did not discriminate 
among the CHF groups, but was significantly depressed overall in CHF as 
compared to control (" p < 0,01), However. the diastasis voluree-% was 
significantly different between the low and the normal EF groups ('p = 0.006) 
as well as between the moderately impaired and the normal EF groups ('p = 
0,04). Control dlastasls volume-% was different from the low and nom~al EF 
CHF groups (~) btzt not tam that of the moderately impaired CHF group. We 
conclude that: (1) Early peak tilling rate alone does not differentiate patients 
with heart failure who exhibit mixed systolic and diastolic dysfunction. (2) The 
disstesis volume-% measure, in concert with peak filling rate and election 
traction, ytelds a composite picture of heart dysfunction that suggest different 
mechanisms for clinical heart failure, 
group LVEF dies, vol% PFR tEDV/s) NYHA Class 
EF ,~35% 26 t 9 TM 93 -~ 5"" 1.5 ~ 13 ~ 21 t 07 
EF 36-55% 44 + 6"" 83 ~ 11" 1 a ~ 0.3 x 1 6 t 0.5 
EF ~55% 64 i 7 "'x 65 t tO ~ 1.5 L 1.0 ~ 1.8 ± 05 
Control 78 ~_ 3 x 86 ± 24 4.1 ± 0.2 x n/a 
"" All CHF groups significantly different lrom each other. Xcontrol different from CHF 
grr~up, and" significantly different from normal EF CHF group. 
• Contra~t-enhanced Color Doppler 
E,chocardlography Improves Measurement o f  Left 
Ventrlcular Volumes In Di lated Hearts: 
Comparison With Magnet ic  Resonance Imaging 
A, Hla. H. Spindola-Franco, M. Chandra, J.A. Meisner, J.A. Strom, 
T.H. Lejemtel, J. Shlrani. Albert Einstein College of Medicine. Bronx. NY. 
USA 
Bac,~gwound: Measurement of left ventricular (LV) end-diastolic and end-sys- 
